2Exanthematous diseases are frequently of infectious origin, posing risks, especially for 3 pregnant healthcare workers (HCWs) who treat them. The shift from cell-mediated (Th1 4 cytokine profile) to humoral (Th2 cytokine profile) immunity during pregnancy can influence the 5 mother's susceptibility to infection and lead to complications for both mother and fetus. The 6 potential for vertical transmission must be considered when evaluating the risks for pregnant 7 HCWs treating infected patients, as fetal infection can often have devastating consequences.
8Given the high proportion of women of childbearing age among HCWs, the pregnancy-related 9 risks of infectious exposure are an important topic in both patient care and occupational health. 10 Contagious patients with cutaneous manifestations often present to dermatology or pediatric 11 clinics, where female providers are particularly prevalent, as a growing number of these 12 physicians are female. Unfortunately, the risks of infection for pregnant HCWs are not well 13 defined. To our knowledge, there is limited guidance on safe practices for pregnant HCWs who 14 encounter infectious dermatologic diseases. In this article, we review several infectious 15 exanthems, their transmissibility to pregnant women, the likelihood of vertical transmission, and 16 the potential consequences of infection for the mother and the fetus. Additionally, we discuss 17 recommendations with respect to avoidance, contact and respiratory precautions, and the need 18 Sungkate et al., 2017) have demonstrated risk of transmission of parvovirus infection to HCWs 62 following exposure to infected patients. One single-center study at Children's Hospital of 63 Philadelphia found elevated risk of infection between exposed and unexposed staff (Bell et al., 64 1998). However, a cohort study of 87 HCWs exposed to two patients with parvovirus B19-65 induced aplastic crisis found no significant increase in parvovirus B19-specific immunoglobulin 66 M (IgM) and immunoglobulin G (IgG) antibodies when compared with unexposed health care 67 workers in the same facility (Ray et al., 1997).
68While the risk of transmission to HCWs has not been definitively identified, preventing 69 the transmission of PVB19 infection is important as it can lead to adverse pregnancy outcomes.
70PVB19 infection carries a 9% excess risk of miscarriage within the first 20 weeks of gestation, 71 and 2.9% risk of fetal hydrops between weeks 9 and 20 (Miller et al., 1998). 72 Management Recommendations: 73 It is recommended that pregnant HCWs should not be part of the care team for patients 74 with suspected PVB19 infection if possible. If exposure is suspected, risk assessment should 75consider the presence of an ongoing outbreak, as well as the extent of contact that the HCW had 76 with exposed patients. Droplet precautions should be strictly followed when caring for patients 77 with PVB19. Please refer to Table 1 for the different types of infection control and prevention 78 precautions. If a pregnant HCW is exposed to a kn...